PTC Therapeutics, Inc. Equity Securities, FV-NI, Unrealized Gain
PTC Therapeutics, Inc. (PTCT) reported Equity Securities, FV-NI, Unrealized Gain of $700.00 thousand for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-10-28.
Discontinued › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiUnrealizedGain · last filed 2021-10-28
- PTC Therapeutics, Inc. equity securities, fv-ni, unrealized gain for the quarter ending 2021-09-30 was $700.00K.
| Period end | Equity Securities, FV-NI, Unrealized Gain 3 month | Equity Securities, FV-NI, Unrealized Gain 9 month |
|---|---|---|
| 2021-09-30 | $700.00K 10-Q · filed 2021-10-28 | $1.40M 10-Q · filed 2021-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |